(Q46332961)

21 December 2017

title

Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild (English)

1 reference

21 December 2017

0 references

5

1 reference

21 December 2017

Rafael Villafuerte

7

1 reference

21 December 2017

Francisca Castro

object named as

Francisca Castro

3

0 references

Catarina Ferreira

object named as

Catarina Ferreira

1

0 references

Pablo Ferreras

object named as

Pablo Ferreras

4

0 references

author name string

Esther Ramírez

2

1 reference

21 December 2017

Steve Redpath

6

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

21 December 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 December 2017

volume

27

1 reference

21 December 2017

issue

50

1 reference

21 December 2017

page(s)

6998-7002

1 reference

21 December 2017

Towards a unique and transmissible vaccine against myxomatosis and rabbit haemorrhagic disease for rabbit populations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

A review of myxomatosis among rabbits in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Vaccination Success and Body Condition in the European Wild Rabbit: Applications for Conservation Strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Epidemiology of viral haemorrhagic disease and myxomatosis in a free-living population of wild rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Effects of vaccination against viral haemorrhagic disease and myxomatosis on long-term mortality rates of European wild rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

SHORT-TERM NEGATIVE EFFECTS OF VACCINATION CAMPAIGNS AGAINST MYXOMATOSIS AND VIRAL HEMORRHAGIC DISEASE (VHD) ON THE SURVIVAL OF EUROPEAN WILD RABBITS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

QUARANTINE LENGTH AND SURVIVAL OF TRANSLOCATED EUROPEAN WILD RABBITS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

The use of immunization programs in wild populations: Modelling effectiveness of vaccination campaigns against rabbit hemorrhagic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

The use of ferrets (Mustela furo) in the study and management of the European wild rabbit (Oryctolagus cuniculus)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Key role of European rabbits in the conservation of the Western Mediterranean basin hotspot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Rabbit populations and game management: the situation after 15 years of rabbit haemorrhagic disease in central-southern Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Passive immunity in myxomatosis of the European rabbit (Oryctolagus cuniculus): the protection conferred on kittens born by immune does

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Waning of maternal immunity and the impact of diseases: the example of myxomatosis in natural rabbit populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Vaccination of free-living juvenile wild rabbits (Oryctolagus cuniculus) against myxomatosis improved their survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Characterisation of immunosuppression in rabbits after infection with myxoma virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Long-term decline of the European wild rabbit (Oryctolagus cuniculus) in south-western Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

The effect of exclusion of terrestrial predators on short-term survival of translocated European wild rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Myxoma virus in the European rabbit: interactions between the virus and its susceptible host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Adverse reactions in wild, free-ranging European rabbits vaccinated against rabbit haemorrhagic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

FIRST EPIZOOTIC OF RABBIT HEMORRHAGIC DISEASE IN FREE LIVING POPULATIONS OF ORYCTOLAGUS CUNICULUS AT DOÑANA NATIONAL PARK, SPAIN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

Hunting for answers: rabbit (Oryctolagus cuniculus) population trends in northeastern Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.075

10.1016/J.VACCINE.2009.09.075

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017